European Union - English - EMA (European Medicines Agency)

ceva santé animale - clostridium perfringens type c, beta1 toxoid / clostridium perfringens, type a, alpha toxoid / clostridium perfringens, type a, beta2 toxoid / escherichia coli, fimbrial adhesin f4ab / escherichia coli, fimbrial adhesin f4ac / escherichia coli, fimbrial adhesin f5 / escherichia coli, fimbrial adhesin f6 - immunologicals for suidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) escherichia + clostridium - pigs - for the passive immunisation of progeny by active immunisation of pregnant sows and gilts to reduce:-           clinical signs (severe diarrhoea) and mortality caused by escherichia coli strains expressing the fimbrial adhesins f4ab, f4ac, f5 and f6-           clinical signs (diarrhoea during the first days of life) associated with clostridium perfringens type a expressing alpha and beta 2 toxins-           clinical signs and mortality associated with haemorrhagic and necrotising enteritis caused by clostridium perfringens type c expressing beta1 toxin

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

laboratorios hipra s.a. - escherichia coli f6 fimbrial adhesin ; eschericia coli lt-enterotoxoïd ; escherichia coli f4ac fimbrial adhesin ; escherichia coli f4ab fimbrial adhesin ; clostridium novyi toxoid ; escherichia coli f5 fimbrial adhesin ; clostridium perfringens type c toxoid - suspension for injection - clostridium perfringens; clostridium novyi toxoid; escherichia coli enterotoxin lt; escherichia coli adhesins - escherichia + clostridium - pig

Philippines - English - FDA (Food And Drug Administration)

msd animal health (phils.), inc. - escherichia coli fimbrial adhesins , clostridium perfringens vaccine (vet.) - suspension for injection (im) - each (2 ml) dose contains: escherichia coli (f4ab adhesin) (ja221-ppab-2 strain) ............ e. coli (f4ac adhesin) (5k-ppac-2 strain) ... ... ... ... ... ... ... ... ... ... e. coli (f5 adhesin) (dh5q-pk99-blue strain) ............. e. coli (f6 adhesin) (987p-5 strain) .............................. e. coli (lt toxoid) (ja221-pplt-1 strain) ...... clostridium perfringens type c antigen (578 strain) .......... ab-antibody titre 29.3 log2 ab titre 26.5 log2 ab titre 27.5 log2 ab titre 27.4 log2 ab titre 210.5 log2 ab titre 20 iu

European Union - English - EMA (European Medicines Agency)

intervet international bv - clostridium perfringens type c / escherichia coli f4ab / e. coli f4ac / e. coli f5 / e. coli f6 / e. coli lt - immunologicals - pigs - for the passive immunisation of progeny by active immunisation of sows and gilts to reduce mortality and clinical signs during the first days of life, caused by those escherichia coli strains which express the adhesins f4ab (k88ab), f4ac (k88ac), f5 (k99) or f6 (987p) and caused by clostridium perfringens type c.,

Philippines - English - FDA (Food And Drug Administration)

boehringer ingelheim animal health philippines, inc.; distributor: boehringer ingelheim animal health philippines, inc. - inactivated escherichia coli fimbrial adhesins , clostridium perfringens b-toxoid vaccine (vet.) - emulsion for injection (im) - formulation: each 2 ml (dose) contains: escherichia coli, f6 adhesins (p4 strain) ......... 21 rp f18ab adhesins (p5 strain) ....... 2 1 rp f4ac adhesins (p6 strain) 2 1 rp f18ac adhesins (p9 strain) .......... 2 1 rp f5 + f41 adhesins (p10 strain) .... 21 rp clostridium perfringens, type c, b-toxoid (czv13 strain) ............ 2 10 iu rp - relative potency iu - international unit (b-antitoxin per ml of rabbit serum)

Philippines - English - FDA (Food And Drug Administration)

elanco philippines, inc.; distributor: elanco philippines, inc. - inactivated clostridium perfringens , escherichia coli vaccine (vet.) - solution for injection (im) - each 2 ml (dose) contains: clostridium perfringens (type c) ............ escherichia coli k99 (b44 strain) ...... escherichia coli k99 + f41 (b41 strain) ... escherichia coli k88, (1769 strain) .................. escherichia coli 987p (1592 strain) ............... cpu-colony plate unit od-optical density 2621 cpu 20.53 od 23.7 od 21.8 od 23.8 od

Philippines - English - FDA (Food And Drug Administration)

zoetis philippines, inc.; distributor: zoetis philippines, inc. - inactivated escherichia coli fimbrial adhesins , clostridium perfringens vaccine (vet.) - suspension for injection (im/sc) - formulation: each (2 ml) dose contains: escherichia coli k99 + f41 adhesin (nadc 1471 strain) ...................>1.36 rp 987p adhesin (nadc 1413 strain) ............................. >1.44 rp k88 adhesin (pps002 strain).................>1.41 rp ltb adhesin(nl-1001 strain) ...................... >1.62 rp k99 adhesin (nl-1005 strain) .................>1.48 rp clostridium perfringens type c antigen (nl-1003 strain) ...........>10 iau rp-relative potency iau-international antitoxin unit

Philippines - English - FDA (Food And Drug Administration)

msd animal health (phils.), inc.; distributor: msd animal health (phils.), inc. - modified live porcine rotavirus , clostridium modified live porcine rotavirus , clostridium perfringens , escherichia coli vaccine (vet.) - freeze-dried vaccine freeze-dried vaccine. for solution (im) - formulation: each dose contains: porcine rotavirus, serogroup a (serotype g4 & g5)....... 26.2 login tcid50 escherichia coli (strain 80-2575) k88 21.3 rp (strain nadc 1471) k99.. 21.3 rp (strain nadc 1413) 987p. 1.2 rp (strain nadc 1471) f41.. ≥1.4 rp clostridium perfringens, type c (strain 4407)... ≥10 iau rp relative potency jau – international antitoxin units tcid – tissue culture infectious dose

United States - English - NLM (National Library of Medicine)

deseret biologicals, inc. - clostridium difficile (unii: pjx89v9r6n) (clostridium difficile - unii:pjx89v9r6n) - clostridium difficile 15 [hp_x] in 1 ml - for temporary relief of symptoms related to clostridium difficile which include occasional diarrhea, intestinal cramping and fevers.** **these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration. for temporary relief of symptoms related to clostridium difficile which include occasional diarrhea, intestinal cramping and fevers.** **these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration.

United States - English - NLM (National Library of Medicine)

deseret biologicals, inc. - clostridium difficile (unii: pjx89v9r6n) (clostridium difficile - unii:pjx89v9r6n) - clostridium difficile 15 [hp_x] in 1 ml - for temporary relief of symptoms related to clostridium difficile which include uncontrollable diarrhea, intestinal cramping and fevers.** **these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration. for temporary relief of symptoms related to clostridium difficile which include uncontrollable diarrhea, intestinal cramping and fevers.** **these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration.